MYX mayne pharma group limited

Mayne Pharma executes asset purchase agreement for Rhofade

  1. 1,060 Posts.
    lightbulb Created with Sketch. 86
    Well done Mayne Pharma . This represents $7 million added to Dermatology gross profit using the existing sales team . Rhofade was the highest generating revenue out of all Novan products , another $12 m added to Mayne total revenue . Great achievement
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.03
Change
-0.020(0.40%)
Mkt cap ! $407.8M
Open High Low Value Volume
$5.00 $5.04 $4.80 $949.0K 192.3K

Buyers (Bids)

No. Vol. Price($)
1 12976 $5.03
 

Sellers (Offers)

Price($) Vol. No.
$5.04 5294 4
View Market Depth
Last trade - 10.51am 21/07/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.